| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
single-strand-selective monofunctional uracil-DNA glycosylase 1 | 0.322 | 0.923 | 4.5E-04 |
|
phenotype | 0.100 | None | 0.867 | 15 | 0 | 2017 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.100 | None | 1.000 | 13 | 0 | 1992 | 2018 | ||||||||
|
C-C motif chemokine ligand 27 | 0.502 | 0.846 | 1.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 13 | 0 | 2009 | 2019 | ||||||||
|
PDZ and LIM domain 3 | 0.547 | 0.769 | 3.0E-07 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2015 | 2019 | ||||||||
|
alkaline phosphatase, placental | 0.487 | 0.808 | 1.8E-13 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2015 | 2019 | ||||||||
|
N-acetyltransferase 10 | 0.536 | 0.769 | 4.1E-22 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2015 | 2019 | ||||||||
|
asparaginase and isoaspartyl peptidase 1 | 0.494 | 0.808 | 2.8E-05 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2015 | 2019 | ||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2015 | 2019 | |||||||||
|
attractin like 1 | 0.546 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2015 | 2019 | ||||||||
|
secretory leukocyte peptidase inhibitor | 0.449 | 0.846 | 9.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2015 | 2019 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
phenotype | 0.100 | None | 1.000 | 10 | 0 | 2005 | 2019 | ||||||||
|
thyroid stimulating hormone receptor | 0.486 | 0.808 | 3.0E-15 |
|
phenotype | 0.090 | None | 0.889 | 9 | 4 | 1998 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.090 | None | 0.889 | 9 | 4 | 1990 | 2019 | ||||||||
|
RUNX family transcription factor 2 | 0.437 | 0.846 | 0.95 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 2017 | 2019 | ||||||||
|
bone gamma-carboxyglutamate protein | 0.462 | 0.846 | 4.6E-08 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 2013 | 2019 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2015 | 2018 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.060 | None | 1.000 | 6 | 2 | 2010 | 2019 | ||||||||
|
thyroglobulin | 0.480 | 0.808 | 2.9E-59 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2010 | 2018 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2011 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.050 | None | 1.000 | 5 | 2 | 2000 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2015 | 2018 | ||||||||
|
cytochrome P450 family 11 subfamily B member 2 | 0.553 | 0.615 | 7.1E-19 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | ||||||||
|
S100 calcium binding protein A1 | 0.421 | 0.846 | 6.0E-03 |
|
phenotype | 0.040 | None | 0.750 | 4 | 0 | 2014 | 2019 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2020 |